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Abstract
Small bowel Dieulafoy lesion is a rare vascular abnormality (1% of all gastrointestinal Dieulafoy lesions) and is mostly
located in the jejunum. Its clinical presentation is recurrent obscure-overt gastrointestinal bleeding severe enough to require
hospitalization and blood transfusions. Till the beginning of the new millennium, small bowel Dieulafoy lesion was
detected only by laparotomy; tremendous advances in the endoscopic ﬁeld, with the advent of capsule endoscopy and
device-assisted enteroscopy, now allow the identiﬁcation of this lesion early in the diagnostic workup of obscure gastro-
intestinal bleeding. In this article, a short capsule endoscopy video of a well-documented midileal Dieulafoy lesion is
reported. This article is part of an expert video encyclopedia.
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Video Related to this Article
Materials
• PillCam SB2 (given imagings; Yokneam, Israel).
• RAPID 5 software (given imagings; Yokneam, Israel).
Background and Endoscopic Procedure
A 62-year-old man was referred from another hospital for
intermittent obscure-overt gastrointestinal bleeding.1 Melena
started 2 months earlier, and previous esophagogastroduo-
denoscopies, colonoscopy, and angiography were all un-
revealing. Bleeding never resulted in shock or syncope;
however, three units of packed red blood cells were required
weekly to keep the hemoglobin level up to 110 g l1. Eight
years before admission, the patient underwent an urgent right
hemicolectomy for peritonitis due to right-sided diverticulitis.
On the day of admission, he presented with melena; although
he was hemodynamically stable, his hemoglobin level was
68 g l1. After blood transfusions, he underwent capsule en-
doscopy, disclosing fresh blood in the upper quartile of the
small bowel; however, a subsequent push enteroscopy,
allowed for 60 cm beyond the ligament of Treitz, was normal.
On the third day of hospitalization, a second capsule revealed
a tiny, round, red mucosal break located in the mid-small
bowel (52% of the time elapsed from the pylorus). In con-
sideration of (1) active bleeding, (2) distance of the lesion
from mouth and anus, (3) uncertainty as to the best route of
insertion of device-assisted enteroscopy, (4) the risk of poor
enteroscope progression due to potential adhesions from
previous surgery, and (5) the low surgical risk, it was decided
to perform an intraoperative enteroscopy, which was done
across a small enterotomy next to a visible clot. The only
identiﬁed abnormality was a 3-mm area of denudated,
bleeding mucosa, 5 cm above the enterotomy. A 15-cm ileal
resection with side-to-side anastomosis was performed. The
postoperative period was uneventful and the patient was dis-
charged after 10 days. Dieulafoy lesion was histologically
conﬁrmed. At a follow-up visit, the patient was well, with
hemoglobin levels within the normal range.
Comment
In up to 5% of overt gastrointestinal hemorrhages, the source
of bleeding cannot be found by urgent upper and lower en-
doscopy and small bowel series.2 Capsule endoscopy has been
recommended as a ﬁrst-line diagnostic investigation in
hemodynamically stable patients. In this patient, the ﬁrst
capsule endoscopy was misleading, yielding luminal blood in
the upper small bowel quartile but no ﬁndings at the sub-
sequent push enteroscopy; hence, the ﬁrst lesson from this
case is that, in the small bowel lumen, blood may move up-
stream from the bleeding point, and only if blood is seen on
capsule endoscopy, the culprit lesion may be located at a
distance. A second-look capsule eventually established the
etiological diagnosis, in agreement with the ﬁndings of Viazis,
who showed the utility of this strategy after a ﬁrst negative or
inconclusive examination of patients with ongoing obscure-
overt bleeding and a signiﬁcant drop in hemoglobin levels.3
Dieulafoy lesion is an anomalous artery lying just under the
epithelial layer of the gastrointestinal tract.4 Histologically, it is
an enlarged, tortuous artery, without signs of atherosclerosis or
vasculitis. Classically, the artery is 1–3 mm in diameter, far
larger than those in the neighboring submucosa. Endoscopic
diagnostic criteria for Dieulafoy lesion are: (1) active arterial
spurting or micropulsatile streaming from a minute mucosal
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defect or through normal surrounding mucosa, (2) visual-
ization of a protruding vessel with or without active bleeding,
and (3) fresh adherent clot with a narrow point of attachment
to a minute mucosal defect or to normal appearing mucosa.
However, direct translation of these criteria to the capsule en-
doscopy setting may be infeasible, due to the capsule’s inability
to manipulate and observe the lesion in real time. To the
author’s knowledge, no formal morphological criteria have
been depicted for Dieulafoy lesion on capsule endoscopy; in
this patient, Dieulafoy lesion appeared as a tiny, round, bulls-
eye-shaped mucosal break with bleeding stigmata.
Very few ileal Dieulafoy lesions have been reported so far,
and this is the ﬁrst case diagnosed by capsule endoscopy with
subsequent histological conﬁrmation. It is conceivable that
further cases will be reported in the next few years, along with
the wider diffusion of device-assisted enteroscopy and capsule
endoscopy.
Key Learning Points/Tips and Tricks
• When luminal blood is the only capsule ﬁnding, the source
of bleeding can be very distant from the location where
blood is encountered.
• In patients with obscure-overt gastrointestinal bleeding
and continuous drop in hemoglobin level, a second-look
capsule may be appropriate.
• During the video interpretation, the frame rate must not
exceed 16–18 frames per second. Tiny but highly diag-
nostic images may be missed at higher frame rates.
Scripted Voiceover
Time
(min:sec)
Voiceover text
00:00 In this video you can see the second capsule endoscopy
performed on this patient with ongoing obscure overt
gastrointestinal bleeding. A ﬁrst capsule endoscopy, two
days earlier, only showed fresh blood at the end of ﬁrst
quartile of the entire length of the small bowel recording,
but a subsequent push enteroscopy, failed to identify
any lesion.
00:40 Frames shown here are actually at 1 h and 15 min from
capsule ingestion, exactly half of the small bowel
recording time. In these frames, luminal content is
scarce and increasingly dark. There are some bubbles,
limiting the endoscopic view to some extent.
01:00 However, in the next few frames, on the left side of the
screen, you will be able to see a tiny, round, red, bulls-
eye shaped lesion, consistent with Dieulafoy’s.
01:25 Subsequent frames, until the end of the video show only
liquid, dark content consistent with recent bleeding.
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